IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist
- PMID:22315422
- PMCID: PMC3286950
- DOI: 10.1073/pnas.1121534109
IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist
Abstract
The functional role of IL-1 family member 10, recently renamed IL-38, remains unknown. In the present study we aimed to elucidate the biological function of IL-38 and to identify its receptor. Heat-killed Candida albicans was used to stimulate memory T-lymphocyte cytokine production in freshly obtained human peripheral blood mononuclear cells from healthy subjects. The addition of recombinant IL-38 (152 amino acids) inhibited the production of T-cell cytokines IL-22 (37% decrease) and IL-17 (39% decrease). The reduction in IL-22 and IL-17 caused by IL-38 was similar to that caused by the naturally occurring IL-36 receptor antagonist (IL-36Ra) in the same peripheral blood mononuclear cells cultures. IL-8 production induced by IL-36γ was reduced by IL-38 (42% decrease) and also was reduced by IL-36Ra (73% decrease). When human blood monocyte-derived dendritic cells were used, IL-38 as well as IL-36Ra increased LPS-induced IL-6 by twofold. We screened immobilized extracellular domains of each member of the IL-1 receptor family, including the IL-36 receptor (also known as "IL-1 receptor-related protein 2") and observed that IL-38 bound only to the IL-36 receptor, as did IL-36Ra. The dose-response suppression of IL-38 as well as that of IL-36Ra of Candida-induced IL-22 and IL-17 was not that of the classic IL-1 receptor antagonist (anakinra), because low concentrations were optimal for inhibiting IL-22 production, whereas higher concentrations modestly increased IL-22. These data provide evidence that IL-38 binds to the IL-36R, as does IL-36Ra, and that IL-38 and IL-36Ra have similar biological effects on immune cells by engaging the IL-36 receptor.
Conflict of interest statement
The authors declare no conflict of interest.
Figures







Similar articles
- Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36α, IL-36β, and IL-36γ) or antagonist (IL-36Ra) activity.Towne JE, Renshaw BR, Douangpanya J, Lipsky BP, Shen M, Gabel CA, Sims JE.Towne JE, et al.J Biol Chem. 2011 Dec 9;286(49):42594-42602. doi: 10.1074/jbc.M111.267922. Epub 2011 Sep 29.J Biol Chem. 2011.PMID:21965679Free PMC article.
- IL-36R ligands are potent regulators of dendritic and T cells.Vigne S, Palmer G, Lamacchia C, Martin P, Talabot-Ayer D, Rodriguez E, Ronchi F, Sallusto F, Dinh H, Sims JE, Gabay C.Vigne S, et al.Blood. 2011 Nov 24;118(22):5813-23. doi: 10.1182/blood-2011-05-356873. Epub 2011 Aug 22.Blood. 2011.PMID:21860022
- Biology of IL-36 cytokines and their role in disease.Gresnigt MS, van de Veerdonk FL.Gresnigt MS, et al.Semin Immunol. 2013 Dec 15;25(6):458-65. doi: 10.1016/j.smim.2013.11.003. Epub 2013 Dec 17.Semin Immunol. 2013.PMID:24355486Review.
- IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells.Strengell M, Lehtonen A, Matikainen S, Julkunen I.Strengell M, et al.J Leukoc Biol. 2006 Jun;79(6):1279-85. doi: 10.1189/jlb.0905503. Epub 2006 Mar 21.J Leukoc Biol. 2006.PMID:16551679
- Role of IL-38 and its related cytokines in inflammation.Yuan X, Peng X, Li Y, Li M.Yuan X, et al.Mediators Inflamm. 2015;2015:807976. doi: 10.1155/2015/807976. Epub 2015 Mar 19.Mediators Inflamm. 2015.PMID:25873772Free PMC article.Review.
Cited by
- New Insights in the Immunobiology of IL-1 Family Members.van de Veerdonk FL, Netea MG.van de Veerdonk FL, et al.Front Immunol. 2013 Jul 8;4:167. doi: 10.3389/fimmu.2013.00167. eCollection 2013.Front Immunol. 2013.PMID:23847614Free PMC article.
- Interleukin-22: immunobiology and pathology.Dudakov JA, Hanash AM, van den Brink MR.Dudakov JA, et al.Annu Rev Immunol. 2015;33:747-85. doi: 10.1146/annurev-immunol-032414-112123. Epub 2015 Feb 11.Annu Rev Immunol. 2015.PMID:25706098Free PMC article.Review.
- Interleukin-38 suppresses abdominal aortic aneurysm formation in mice by regulating macrophages in an IL1RL2-p38 pathway-dependent manner.Kurose S, Matsubara Y, Yoshino S, Yoshiya K, Morisaki K, Furuyama T, Hoshino T, Yoshizumi T.Kurose S, et al.Physiol Rep. 2023 Jan;11(2):e15581. doi: 10.14814/phy2.15581.Physiol Rep. 2023.PMID:36708509Free PMC article.
- Interleukin-36 Cytokines in Infectious and Non-Infectious Lung Diseases.Peñaloza HF, van der Geest R, Ybe JA, Standiford TJ, Lee JS.Peñaloza HF, et al.Front Immunol. 2021 Nov 23;12:754702. doi: 10.3389/fimmu.2021.754702. eCollection 2021.Front Immunol. 2021.PMID:34887860Free PMC article.Review.
- Neuroprotective pentapeptide CN-105 is associated with reduced sterile inflammation and improved functional outcomes in a traumatic brain injury murine model.Laskowitz DT, Wang H, Chen T, Lubkin DT, Cantillana V, Tu TM, Kernagis D, Zhou G, Macy G, Kolls BJ, Dawson HN.Laskowitz DT, et al.Sci Rep. 2017 Apr 21;7:46461. doi: 10.1038/srep46461.Sci Rep. 2017.PMID:28429734Free PMC article.
References
- Costelloe C, et al. IL-1F5 mediates anti-inflammatory activity in the brain through induction of IL-4 following interaction with SIGIRR/TIR8. J Neurochem. 2008;105:1960–1969. - PubMed
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous